Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.12 | -49,84% | -29,25% | 708.637,05 | 0,66% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
154.28 | 0% | 0% | 367.427,71 | 3,25% | 2,71% |
|
NYSE:MRK
Merck
|
130.88 | -10,39% | 2,75% | 333.646,57 | 2,34% | -19,03% |
|
NYSE:ABBV
AbbVie
|
164.35 | -21,82% | -11,49% | 289.231,48 | 3,79% | 7,03% |
|
SWX:NOVN
Novartis
|
92.62 | 8,23% | 21,62% | 190.369,92 | 3,54% | 4,67% |
|
SWX:ROG
Roche Holding
|
234.80 | 30,63% | 46,57% | 183.645,06 | 4,22% | 0,43% |
|
NYSE:ABT
Abbott Laboratories
|
104.87 | 1,94% | 14,62% | 181.948,29 | 2,1% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
314.72 | -14,06% | -5,45% | 171.144,12 | 2,82% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.92 | 7,74% | 37,79% | 163.311,21 | 5,83% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
90.24 | 17,5% | 36,18% | 113.210,59 | 4,15% | 8,19% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.11 | 59,85% | 70,07% | 90.307,31 | 5,39% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.86 | 22,18% | 31,53% | 83.479,36 | 4,6% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
168.70 | 3,79% | 18,65% | 72.107,91 | 1,33% | 10,73% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4138.00 | 0% | 0% | 6.525.195,89 | 4,74% | 0% |
|
NasdaqGS:BIIB
Biogen
|
230.04 | -16,94% | -2,2% | 34.261,86 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
28.65 | 63,25% | 79,18% | 28.809,59 | 0,38% | 1,47% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.30 | -47,78% | -44,41% | 19.005,71 | 0% | -2,6% |
|
NasdaqGS:INCY
Incyte
|
56.86 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
|
ENXTPA:IPN
Ipsen
|
121.40 | -14,58% | -6,56% | 9.878,9 | 0,99% | 9,14% |
|
NasdaqGS:EXEL
Exelixis
|
21.23 | 39,15% | 69,39% | 6.338,53 | 0% | -8,84% |
